Lifespan adversity and later adulthood telomere length in the nationally representative US Health and Retirement Study

Telomeres » Institutional Study » Lifespan adversity and later adulthood telomere length in the nationally representative US Health and Retirement Study

March 20, 2017 | Amy | Leave a comment

Peer-Reviewed Scientific Journal:
Proceedings of the National Academy of Sciences

Size of study:
4,598 men and women from the US Health and Retirement Study

Summary
Each instance of a social/traumatic stress event in childhood predicted 11% increased probability of having short telomeres. This study may show that childhood adversity persists into later adulthood in the form of advanced cellular aging.

Link to study

SEE THE FULL STUDY

Leave a Reply Cancel reply

The TeloYears test is not intended for screening, diagnosing, treating or preventing diseases or medical conditions. The TeloYears genetic test may indicate the possibility of identifying a rare telomere syndrome associated with extremely shorter or longer average telomere length (ATL). In these rare cases, further testing and consultation with a doctor to rule in or rule out a telomere syndrome is recommended. The test is available for individuals between the ages of 20 to 80 within the United States, except for the states of Maryland and New York. The information provided by the TeloYears test should not be used to replace medically appropriate screening tests recommended based upon actual age or other risk factors, nor should the information be used to make decisions about diagnosis or treatment of diseases or medical conditions. The Telomere Diagnostics lab is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by Telomere Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration.